Annovis Bio slips after pricing $15M equity offering
Annovis Bio's stock experienced a decline after the company announced the pricing of a $15 million underwritten public offering of its common stock. T...
Annovis Bio's stock experienced a decline after the company announced the pricing of a $15 million underwritten public offering of its common stock. T...